CINECA IRIS Institutional Research Information System

BALDESCHI, LELIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.688
AS - Asia 4.124
EU - Europa 3.013
SA - Sud America 589
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 68
OC - Oceania 10
Totale 15.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.313
CN - Cina 1.129
SG - Singapore 1.058
IT - Italia 1.056
HK - Hong Kong 683
BR - Brasile 464
SE - Svezia 399
BG - Bulgaria 285
VN - Vietnam 262
UA - Ucraina 252
CA - Canada 248
DE - Germania 231
TR - Turchia 196
KR - Corea 172
FI - Finlandia 155
FR - Francia 152
GB - Regno Unito 133
IN - India 132
RU - Federazione Russa 113
CH - Svizzera 112
JP - Giappone 111
BD - Bangladesh 98
IQ - Iraq 59
SA - Arabia Saudita 36
ID - Indonesia 32
NL - Olanda 32
AR - Argentina 30
MX - Messico 29
PK - Pakistan 29
CI - Costa d'Avorio 28
VE - Venezuela 27
JM - Giamaica 23
ZA - Sudafrica 23
KE - Kenya 22
UZ - Uzbekistan 21
MA - Marocco 19
AT - Austria 16
BB - Barbados 16
BE - Belgio 16
EC - Ecuador 15
CO - Colombia 14
JO - Giordania 13
PL - Polonia 13
NP - Nepal 12
TT - Trinidad e Tobago 12
EG - Egitto 10
ES - Italia 10
IL - Israele 10
SN - Senegal 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
GR - Grecia 9
AU - Australia 8
HN - Honduras 8
PY - Paraguay 8
TN - Tunisia 8
CL - Cile 7
KZ - Kazakistan 7
PA - Panama 7
UY - Uruguay 7
ET - Etiopia 6
IE - Irlanda 6
PE - Perù 6
AL - Albania 5
AZ - Azerbaigian 5
BJ - Benin 5
BO - Bolivia 5
MY - Malesia 5
OM - Oman 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
IR - Iran 4
LB - Libano 4
LK - Sri Lanka 4
NG - Nigeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AO - Angola 3
GD - Grenada 3
GE - Georgia 3
GT - Guatemala 3
GY - Guiana 3
KW - Kuwait 3
NI - Nicaragua 3
PH - Filippine 3
PT - Portogallo 3
QA - Qatar 3
SR - Suriname 3
BH - Bahrain 2
BS - Bahamas 2
CY - Cipro 2
EU - Europa 2
HU - Ungheria 2
KH - Cambogia 2
KY - Cayman, isole 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
SX - ???statistics.table.value.countryCode.SX??? 2
Totale 15.555
Salva come PNG Salva come JPEG
Città #
Woodbridge 809
Hong Kong 675
Ashburn 658
Singapore 590
Ann Arbor 541
Houston 534
Santa Clara 510
Milan 507
Fairfield 450
Chandler 405
Jacksonville 352
San Jose 351
Sofia 283
Shanghai 236
Ottawa 210
Beijing 208
Dallas 191
Hefei 191
Seattle 191
New York 182
Wilmington 173
Seoul 164
Cambridge 141
Boardman 126
Nanjing 123
Izmir 122
Los Angeles 120
Princeton 115
Bern 111
Lawrence 111
Medford 100
Tokyo 100
Lauterbourg 98
Florence 89
Council Bluffs 71
Dearborn 64
Jüchen 61
Serra 61
Des Moines 55
Ho Chi Minh City 53
Nanchang 53
Istanbul 49
Dong Ket 45
Hanoi 43
Buffalo 42
Helsinki 42
Redondo Beach 39
Rome 39
Kunming 37
Ogden 29
Abidjan 28
Munich 26
Hebei 25
Dhaka 23
São Paulo 23
San Diego 21
Washington 21
Shenyang 20
Frankfurt am Main 18
Hangzhou 17
Nairobi 17
Tashkent 17
Bridgetown 16
Baghdad 15
Kingston 15
Riyadh 15
Lancaster 14
Orange 14
Jeddah 13
London 13
Norwalk 13
Rio de Janeiro 13
Amman 12
Changsha 12
Guangzhou 12
Jiaxing 12
Vienna 12
Boulder 11
Haiphong 11
Pune 11
Belo Horizonte 10
Dakar 10
Redwood City 10
Tianjin 10
Campinas 9
Da Nang 9
Orem 9
Amsterdam 8
Caracas 8
Johannesburg 8
Osaka 8
Cairo 7
Delhi 7
Falkenstein 7
Kathmandu 7
Maracaibo 7
Mumbai 7
Paris 7
Salvador 7
San José 7
Totale 11.202
Salva come PNG Salva come JPEG
Nome #
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 326
Correction of lid retraction and exophthalmos. 210
Is sleeping position related to asymmetry in bilateral Graves' ophthalmopathy? 205
Re: Orbitozygomatic approach for excisions of orbital tumors with 1 piece of craniotomy bone flap: 2 case reports by Chi-Wen Chang et al. Surg Neurol 2007;68(SI):58. 201
Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. 194
Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy. 190
Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections". 189
Glass ionomer implants and tissue aluminum levels: an animal study. 184
A new and validated CT-based method for the calculation of orbital soft tissue volumes. 184
A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. 182
Small versus coronal incision orbital decompression in Graves' orbitopathy. 182
The intranasal ostium after external dacryocystorhinostomy and the internal opening of the lacrimal canaliculi. 182
Correction of lid retraction and exophthalmos. 178
Somatostatin receptor scintigraphy for optic nerve sheath meningiomas. 177
Brachytherapy as part of the multidisciplinary treatment of childhood rhabdomyosarcomas of the orbit. 176
Management of Graves’ orbitopathy in Europe: a questionnaire survey conducted by the European Group on Graves Orbitopathy (EU.GO.GO). 172
Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy 172
Studio delle vie lacrimali con dacriocistografia digitale. [Study of lacrimal system using digital dacryocystography]. 171
The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy. 170
Vitreal and serum growth hormone in proliferative diabetic retinopathy, diabetic retinopathy and in control subjects. 167
Chirurgia della cataratta in presenza di tamponamento interno con olio di silicone. [Cataract surgery with silicon oil in posterior chamber]. 166
Unilateral Graves’ orbitopathy: a case control and retrospective follow up study. 166
Supernumerary extraocular muscle in Graves' orbitopathy. 165
Traumatic neuroma of the infraorbital nerve subsequent to inferomedial orbital decompression for Graves' orbitopathy. 165
The length of unsutured mucosal margins in external dacryocystorhinostomy. 164
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. 164
Uso dell'olio di silicone nel trattamento chirurgico della retinopatia diabetica proliferante: nostra casistica. [Silicon oil in surgical treatment of proliferative diabetic retinopathy: our experience]. 163
Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians. 161
Effetto di colliri antinfiammatori steroidei e non steroidei sulle variazioni dell'astigmatismo corneale dopo estrazione extracapsulare di cataratta. [Effect of steroid and not-steroid anti-inflammatory eye drops on variations of corneal astigmatism after extra capsular cataract extraction]. 159
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. 159
Rehabilitative surgery. 159
Small versus coronal incision orbital decompression in Graves' orbitopathy. 159
Cosa aspettarsi dalla chirurgia decompressiva a tre pareti in caso di orbitopatia distiroidea non complicata da diplopia pre operatoria: Uno studio retrospettivo su 134 pazienti. (What is to be expected by three wall decompression surgery performed on patients affected by dysthyroid orbitopathy without pre operative double vision). 158
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. 157
Selenium and the course of mild Graves' Orbitopathy 156
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy. 156
Efficacy and safety of three different cumulative doses of intraveneous methylprednisolone for moderate to severe and active Graves’ orbitopathy. 155
What should patients with Graves’ orbitopathy without functional deficit should expect from decompression surgery. 154
Graves’ orbitopathy: transmission via bone marrow transplantation? 152
Intranasal ostium after external dacryocystorhinostomy and internal opening of the lacrimal canaliculi. 152
Reactivation of Graves’ orbitopathy after aesthetic orbital decompression. 151
Orbital decompression. 151
Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. 151
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. 149
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 149
Orbital decompressions: status of the art and unresolved issues. 148
Future developments. 148
Sensitivity and specificity of ultrasonography, fluorescein videoangiography, indocyanine green videoangiography, magnetic resonance and radioimmunoscintigraphy in the diagnosis of primary choroidal malignant melanoma. 148
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. 147
A comparison for skin storage methods for oculoplastic surgery 147
The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. 146
Orbital venous anomalies. 144
GH vitreale e sierico nella RDP e in soggetti normali. [Vitreal and serum growth hormone in proliferative diabetic retinopathy and in control subject]. 143
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey 142
Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. 141
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience 141
Effectiveness of early versus late orbital decompression in thyroid related orbitopathy. 139
A questionnaire survey on the management of Graves' orbitopathy in Europe 139
Suture regolabili nel trattamento chirurgico della retrazione della palpebra superiore nell'oftalmopatia Basedowiana: nostra casistica. [Adjustables suture for the correction of upper eyelid retraction in Basedow’s ophthalmopathy: our experience]. 138
Does orbital radiotherapy influence the effect of orbital decompression in Graves’ orbitopathy. 138
Optimising the Rotterdam Fasciatome and Fascia Splitter. 138
Il trattamento chirurgico del pucker maculare. [Surgical treatment of macular pucker]. 134
Trattamento con suture aggiustabili della retrazione palpebrale superiore in corso di oftalmopatia basedowiana 134
The contribution of the deep lateral wall to orbital decompression in thyroid related orbitopathy. 134
Distacco di retina nello pseudofachico. [Retinal detachment in pseudophachic patients]. 133
Anterior suspended flaps: a modified approach for external dacryocystorhinostomy 133
Damage of foldable intraocular lenses by incorrect folder forceps 132
Langzeitergebnisse sekundärer orbitaimplantate (Long-term results of secondary orbital implant). 131
Orbital decompression. 131
Surgical decompression in thyroid eye disease: does the approach matter? 130
Test-retest reliability and responsiveness of the GO-QOL; a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy. 130
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. 130
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. 129
Ocular adnexal lymphomas. 128
Rehabilitative surgery. 128
Sequelae to secondary orbital implant. 127
Intervento modificato di dacriocistorinostomia. [Modified dacryocystorhinostomy]. 126
E.E.C. syndrome: a rare disease with lacrimal drainage disorders. 123
Future developments. 121
Age- and gender related differences in orbital soft tissue volumes unravelled. 120
Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. 119
Drie gevallen van zeldzame metastase naar oog en orbita (Three cases of unusual metastasis to eye and orbit). 118
Bony orbital development after early enucleation in humans. 118
Orbital decompresssion in Graves' orbitopathy: state of the art and novel perspectives. 117
Suture-less trans-fornix approach for infero-medial decompression in dysthyroid orbitopathy. 117
Ultrasonographic and angiographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. 117
Functional and rehabilitative surgery of Graves’ orbitopathy. 115
A case of a late complication after naso-iacrimal duct intubation 114
Upper eyelid lengthening in Graves’ ophthalmopathy. 112
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. 111
Een suspect aspect (A suspect aspect). 110
Long-term results of secondary orbital implants. 110
Evaluation of aesthetic rehabilitation of patients with congenital microphthalmos. 108
Orbital lymphoom. (Orbital lymphomas). 107
Orbitopatia tiroide correlata. [Thyroid Related Orbitopathy] 105
Vergelijking Mullerectomie bij levator desinsertie d.m.v. posterieure versus anterieure benadering. (Comparison of Mullerectomy associated to levator disinsertion throught an anterior or posterior approach). 103
Embrional rhabdomiosarcoma of the orbit. 102
Kanker van de oog en oogkas. [Cancer of the eye and orbit]. 99
Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. 97
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) 94
Totale 14.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022935 0 94 12 60 191 133 14 32 47 13 36 303
2022/20231.177 129 87 70 87 150 194 6 103 205 9 127 10
2023/20241.336 250 213 179 109 190 210 9 24 25 9 27 91
2024/20253.938 13 124 18 120 323 287 283 196 273 421 268 1.612
2025/20262.591 155 461 289 153 216 314 415 103 127 237 96 25
2026/2027269 89 180 0 0 0 0 0 0 0 0 0 0
Totale 15.642